Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 9NIH 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Arthritis, Rheumatoid 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Graft vs Host Disease 6Leukemia 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma 3Psoriasis 2Neoplasms 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Stomatitis 1Recurrence 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Neutropenia 1Mycosis Fungoides 1Multiple Myeloma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoproliferative Disorders 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Methotrexate × Clear all
NCT02393859 2024-05-29

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Amgen

Phase 3 Completed
111 enrolled 23 charts 1 FDA
LymphoidOther hematologic neoplasm

Immunoproliferative Disorders, Lymphoproliferative Disorders, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Amgen

Phase 2 Completed
Breast

Breast Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡